Elypta is a Swedish diagnostic company focused on developing new biomarkers for cancer risk-stratification. The company pursues profiling of glycosaminoglycans (GAGome) as a new category of dynamic biological risk markers with the aim to enable an expansion of cancer screening and prevention. Elypta’s leading indication is lung cancer risk with a broader program targeting multi-cancer risk applications. Elypta also serves the glycosaminoglycan research community with standardized GAGome quantification kits for research use.
| Website | http://elypta.com |
| Employees | 29 (18 on RocketReach) |
| Founded | 2017 |
| Address | Nanna Svartz väg 4, Solna, Stockholm County 171 65, SE |
| Phone | +46 8 520 278 85 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+16 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care |
| Keywords | Cancer Diagnostics, Liquid Biopsy, Cancer Screening, Early Cancer Detection, Cancer Biomarkers, Cancer Detection Technology, Oncology Diagnostics, Molecular Diagnostics, Precision Oncology, Cancer Research, Biomarker Discovery, Diagnostic Testing, Machine Learning Diagnostics, Medical Diagnostics, Proteomics |
| Competitors | Guardant Health, GRAIL, Exact Sciences, Freenome, Oncocyte Corporation, Biocept, Inc., PathAI, Circulogix, Myriad Genetics, Genomic Health +28 more (view full list) |
Looking for a particular Elypta employee's phone or email?
Karl Bergman is the CEO of Elypta.
18 people are employed at Elypta.
Elypta is based in Solna, Stockholm County.